Bruker launches novel MALDI HiPLEX-IHC tissue imaging solution for timsTOF fleX using AmberGen’s HiPLEX-IHC peptide code antibody probes, combined with unbiased lipidomics, glycomics and metabolomics tissue imaging New Canopy CellScape™ single cell, highly quantitative spatial proteomic ChipCytometry™ platform features fully automated iterative staining using open-source antibodies for virtually unlimited immuno-oncology marker analysis on whole tissue […]
Ansa’s next-generation enzymatic DNA synthesis technology will dramatically accelerate innovation across every industry enabled by synthetic DNA from biologic drugs to biomanufacturing, and DNA-based data storage. Funding will advance next-generation technology platform, expand R&D and manufacturing facilities, grow multidisciplinary team, and launch DNA synthesis service. Ansa is solving current industry bottlenecks associated with synthesizing complex […]
Today, Finnish Organ-On-Chip startup Finnadvance announced that they’ve secured a €1.2 million seed financing round led by Finnish investor Athensmed. Several existing investors, such as deep tech VC Voima Ventures and early-stage VC Icebreaker, are participating in the funding round. In addition, the funding also includes a new investor: Takoa Invest. Finnadvance is a biotechnology start-up […]
Transforming Multiomics Spatial Tissue Biology with the Power of MALDI Mass Spectrometry for Imaging Targeted Proteins, Lipids, Glycans and Metabolites WATERTOWN, Massachusetts – Boston-area life science technology company AmberGen Inc. today announced that it has closed a strategic investment by Bruker Corporation, one of the world’s leading scientific instrumentation and life-science solutions companies. AmberGen’s innovative […]
Endava is leveraging its technical capabilities to support SOPHiA GENETICS in its mission to inform the best course of action for patients and research worldwide by democratizing data-driven medicine. SOPHiA GENETICS – a Swiss healthtech company listed on Nasdaq – have engaged Endava to support them in various IT projects across software engineering, technology operations and […]
London, UK — PCR Biosystems has expanded its comprehensive range of diagnostic reagents with the launch of the Lyo-Ready Probe 1-Step Kit, a lyophilisable 4x RT-qPCR reagent mix designed for ultra-sensitive high-throughput detection of RNA sequences. The new reagents will bring the exceptional sensitivity of the company’s liquid format 1-step RT-qPCR reagents to a freeze-dryable […]
Extension of previous funding round brings total raised to £7 million GBP (circa $9.2 million USD) Investment from Calculus Capital, Par Equity, and Scottish Enterprise Funding will support continued development of Axol’s human iPS cell lines and reagents, and expansion of its commercial team Cambridge, UK: Axol Bioscience Ltd. (Axol), an established provider of iPSC-derived cells, […]
Launches first-of-its-kind automated ultrasound platform to accelerate preclinical research WALTHAM, Mass. — PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced the expansion of its in vivo imaging portfolio with the launch of the Vega® imaging system, a first-of-its kind ultrasound platform that combines hands-free, automated technology with high-throughput capability to […]
Dublin, Ireland: ERS Genomics Limited (‘ERS’) is pleased to announce a license agreement with Central Institute for Experimental Animals (“CIEA”) in Japan. This is a non-exclusive licensing agreement granting CIEA access to the ERS CRISPR/Cas9 patent portfolio. ERS, co-founded by Dr. Emmanuelle Charpentier, 2020 Nobel Prize winner for gene-editing, provides access to the foundational CRISPR/Cas9 […]
Advanced Cybersecurity with State-of-the-Art Encryption Features and Biomanufacturing Compliance Enablement SEATTLE — NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial unveiling of the nCounter® Pro Analysis System, the next generation of the nCounter instrument platform. The new system requires minimal bioinformatics support and […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
